Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Collplant Biotechnologies Ltd

Current price
5.95 USD +0.16 USD (+2.76%)
Last closed 5.76 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 65 995 100 USD
Yield for 12 month -18.47 %
21.11.2021 - 28.11.2021

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel. Address: Weizmann Science Park, Rehovot, Israel, 7670104

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

11 USD

P/E ratio

Dividend Yield

Current Year

+10 959 000 USD

Last Year

+299 000 USD

Current Quarter

+299 000 USD

Last Quarter

+299 000 USD

Current Year

+7 866 000 USD

Last Year

-101 000 USD

Current Quarter

-758 000 USD

Last Quarter

-474 000 USD

Key Figures CLGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 410 000 USD
Operating Margin TTM -1694.98 %
PE Ratio
Return On Assets TTM -13.06 %
PEG Ratio
Return On Equity TTM -23.16 %
Wall Street Target Price 11 USD
Revenue TTM 10 959 000 USD
Book Value 2.48 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 415.5 %
Dividend Yield
Gross Profit TTM 13 636 000 USD
Earnings per share -0.62 USD
Diluted Eps TTM -0.62 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -64.05 %

Dividend Analytics CLGN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CLGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 2:3
Payout Ratio
Last Split Date 21.11.2016
Dividend Date 21.11.2016

Stock Valuation CLGN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 15.5521
Enterprise Value Revenue 3.3364
Price Sales TTM 5.4821
Enterprise Value EBITDA -5.7042
Price Book MRQ 2.1199

Financials CLGN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CLGN

For 52 weeks

4.22 USD 8.9 USD
50 Day MA 5.62 USD
Shares Short Prior Month 5 759
200 Day MA 5.7 USD
Short Ratio 1.04
Shares Short 6 782
Short Percent 0.07 %

Dynamics of changes in the value of assets




430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds



14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics